Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Canada’s Pharmascience Renews Agreement With CDMO Saneca Pharma

By Saneca Pharma | March 2, 2018

Contract development and manufacturing organization (CDMO) Saneca Pharma has renewed an agreement with Pharmascience Inc., one of Canada’s largest pharmaceutical companies, for the manufacture and supply of prescription medicines in tablet form.

The agreement, which follows a successful GMP audit held in January 2018, includes the manufacture of 600 million enteric, chewable, and film-coated tablets (RX medicines) per year. It will also involve R&D and laboratory analyses related to existing and emerging formulations, as well as technical support in delivery to the Canadian market.

Pharmascience manufactures and markets prescription, over-the-counter, and behind-the-counter medicines, filling more than 45 million prescriptions each year in Canada. Based in Montreal, the company distributes its products across 60 countries worldwide.

Based in western Slovakia near Vienna, Saneca Pharma offers development and manufacturing capabilities for solids, semi-solids and liquids, as well as specialist services in tech-transfer, opiate APIs, and finished dosage forms.

The substantial agreement consists of nine different stock keeping units (SKUs), covering a number of therapeutic areas. 

“Saneca Pharma is well located in Europe and its experience in manufacturing solid dose products was a huge part of the reason we selected them as our outsourcing partner for this project,” Pierre Plante, sourcing director at Pharmascience, said in a press statement. 

(Source: Saneca Pharma)

Related Articles Read More >

Antheia_Logo (1)
Pharma ingredient manufacturer Antheia raises $56M Series C
Prolific Machines logo.
Prolific Machines enters FDA program to enhance therapeutics manufacturing platform
Genentech roche
Roche, Genentech to build $700M drug manufacturing plant in North Carolina
Amgen
Amgen to spend $900M to expand U.S. biopharma manufacturing
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE